LDS/Medical Tests/Beta-amyloid Protein Ratio 1-42/1-40 (QUEST AD-Detect™, INNOTEST® B-AMYLOID), Plasma

Beta-amyloid Protein Ratio 1-42/1-40 (QUEST AD-Detect™, INNOTEST® B-AMYLOID), Plasma

Amyloid β-protein (Aβ protein) is a peptide released from the proteolytic cleavage of a transmembrane protein called Amyloid β precursor protein. It is one of the major components of the amyloid plaques that are extracellularly deposited in the brain of patients with Alzheimer’s disease. Several Aβ isoforms exist in the brain, however the two main isoforms are Aβ1-40 and Aβ1-42. Although Aβ1-40 is the most prevalent isoform, Aβ1-42 is more prone to aggregate. Aβ protein is considered to be a neurotoxic protein and if believed to play a role in the pathogenesis of Alzheimer’s disease.

Alzheimer’s disease (AD) is a complex progressive neurodegenerative disease characterized by loss of memory and impaired cognitive function. It is believed to be caused by deposition of amyloid plaques and neurofibrillary tangles which are formed from the fibrillar form of Aβ protein and hyperphosphorylated tau (τ) protein, respectively. Measurement of Aβ-protein in CSF can support the clinical diagnosis of AD although it is not required for diagnosis. It may, however, be useful in the evaluation of early onset dementia, atypical AD and in the differential diagnosis of non-amyloid related neurodegenerative disorders. Finally, while Aβ-protein is increased in patients with Down syndrome, and these patients characteristically develop AD, it is rarely used in the diagnosis of this syndrome.

  • As an aid in diagnosis of Alzheimer’s disease
  • Useful in the differential diagnosis of other neurodegenerative disorders
A beta-amyloid ratio (1-42/1-40) greater or equal than 0.17 indicates your results are normal. This suggest that you have lower than normal risk of having AD. A beta-amyloid ratio (1-42/1-40) less than 0.17 (likely positive) suggests a higher than normal of developing or having AD. This may suggest follow-up testing such as PET and CFS biomarkers to support the diagnosis of AD.

≥ 0.17

Radioimmunoassay (RIA), liquid chromatography with tandem mass spectrometry (LC-MS/MS).

Plasma (EDTA).

Stability

Frozen: 30 days

Beta-amyloid 40 (Aβ40), Beta-amyloid 42 (Aβ42), Aβ42/40 ratio, Apolipoprotein E, Tau protein, phosphorylated tau (P-τ), autoantibodies against Aβ, platelet amyloid precursor protein and α-antichymotrypsin.
3-7 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login